Peter Hart

2.5k total citations
24 papers, 1.1k citations indexed

About

Peter Hart is a scholar working on Infectious Diseases, Immunology and Sociology and Political Science. According to data from OpenAlex, Peter Hart has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Immunology and 5 papers in Sociology and Political Science. Recurrent topics in Peter Hart's work include Tuberculosis Research and Epidemiology (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Irish and British Studies (4 papers). Peter Hart is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Irish and British Studies (4 papers). Peter Hart collaborates with scholars based in United States, United Kingdom and Sweden. Peter Hart's co-authors include Joan Selverstone Valentine, Peter M. Andersen, David Borchelt, Mercedes Prudencio, Matthew J. Paul, Rajko Reljić, Alastair Copland, Mahavir Singh, Dale E. Bredesen and David W. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Annals of Neurology.

In The Last Decade

Peter Hart

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hart United States 14 375 343 171 138 119 24 1.1k
Wilian A. Cortopassi United States 16 87 0.2× 537 1.6× 24 0.1× 24 0.2× 100 0.8× 29 1.0k
N.R. Silvaggi United States 20 203 0.5× 557 1.6× 68 0.4× 4 0.0× 117 1.0× 37 1.2k
Mariapina D’Onofrio Italy 24 72 0.2× 929 2.7× 76 0.4× 14 0.1× 11 0.1× 71 1.4k
Artur Giełdoń Poland 19 57 0.2× 546 1.6× 89 0.5× 9 0.1× 19 0.2× 64 890
Anni Zhao United States 8 77 0.2× 542 1.6× 50 0.3× 21 0.2× 9 0.1× 8 875
Martina Vermathen Switzerland 18 76 0.2× 538 1.6× 110 0.6× 18 0.1× 13 0.1× 43 1.6k
Hervé Meudal France 22 61 0.2× 545 1.6× 65 0.4× 9 0.1× 37 0.3× 43 1.1k
Kenji Sasahara Japan 22 50 0.1× 914 2.7× 49 0.3× 18 0.1× 13 0.1× 46 1.3k
Nandini Rangaraj India 24 28 0.1× 1.1k 3.2× 31 0.2× 22 0.2× 24 0.2× 41 1.7k

Countries citing papers authored by Peter Hart

Since Specialization
Citations

This map shows the geographic impact of Peter Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hart more than expected).

Fields of papers citing papers by Peter Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hart. The network helps show where Peter Hart may publish in the future.

Co-authorship network of co-authors of Peter Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hart. A scholar is included among the top collaborators of Peter Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hart. Peter Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paul, Matthew J., Peter Hart, Richard Odame Phillips, et al.. (2025). A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infection. PLoS neglected tropical diseases. 19(2). e0012710–e0012710. 1 indexed citations
2.
Struhl, Melissa Kline, Peter Hart, Sagi Jaffe‐Dax, et al.. (2023). iCatcher+: Robust and Automated Annotation of Infants’ and Young Children’s Gaze Behavior From Videos Collected in Laboratory, Field, and Online Studies. Advances in Methods and Practices in Psychological Science. 6(2). 7 indexed citations
3.
Rigby, Ishmeala, Melina Michelen, Hung‐Yuan Cheng, et al.. (2022). Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines. BMC Medicine. 20(1). 425–425. 3 indexed citations
5.
Lipworth, Samuel, Ishmeala Rigby, Hung‐Yuan Cheng, et al.. (2021). From severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) to coronavirus disease 2019 (COVID-19): a systematic review of the quality and responsiveness of clinical management guidelines in outbreak settings. Oxford University Research Archive (ORA) (University of Oxford). 6. 170–170. 2 indexed citations
6.
Hart, Peter & Jeremy Farrar. (2021). The influenza vaccines roadmap – A better future through improved influenza vaccines. Vaccine. 39(45). 6570–6572.
7.
Paul, Matthew J., Alastair Copland, Peter Hart, et al.. (2020). Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. Frontiers in Immunology. 11. 582833–582833. 18 indexed citations
8.
Copland, Alastair, et al.. (2019). Bacillus Calmette-Guérin Induces PD-L1 Expression on Antigen-Presenting Cells via Autocrine and Paracrine Interleukin-STAT3 Circuits. Scientific Reports. 9(1). 3655–3655. 25 indexed citations
9.
Hart, Peter, Alastair Copland, Miyoung Kim, et al.. (2019). Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG. Frontiers in Immunology. 10. 1349–1349. 20 indexed citations
10.
Copland, Alastair, Peter Hart, Matthew J. Paul, et al.. (2018). Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin. Frontiers in Immunology. 9. 346–346. 46 indexed citations
11.
Joshi, Amit D., Anita Arora, David Cimbaluk, George Dunea, & Peter Hart. (2012). Acute Epstein-Barr virus infection-associated collapsing glomerulopathy. Clinical Kidney Journal. 5(4). 320–322. 15 indexed citations
12.
Prudencio, Mercedes, Peter Hart, David Borchelt, & Peter M. Andersen. (2009). Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Human Molecular Genetics. 18(17). 3217–3226. 203 indexed citations
14.
Valentine, Joan Selverstone & Peter Hart. (2003). Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences. 100(7). 3617–3622. 475 indexed citations
15.
Hart, Peter. (2003). The I.R.A. at War 1916-1923. 21 indexed citations
16.
Valentine, Joan Selverstone, Peter Hart, & Edith Butler Gralla. (1999). Copper-Zinc Superoxide Dismutase and ALS. Advances in experimental medicine and biology. 448. 193–203. 15 indexed citations
17.
Miller, David W. & Peter Hart. (1999). The I.R.A. and Its Enemies: Violence and Community in Cork, 1916-1923. The American Historical Review. 104(5). 1762–1762. 11 indexed citations
18.
Bredesen, Dale E., Lisa Ellerby, Peter Hart, Martina Wiedau‐Pazos, & Joan Selverstone Valentine. (1997). Do posttranslational modifications of CuZnSOD lead to sporadic amyotrophic lateral sclerosis?. Annals of Neurology. 42(2). 135–137. 29 indexed citations
19.
Nersissian, Aram M., Joan Selverstone Valentine, Zara Mehrabian, et al.. (1996). Cloning, expression, and spectroscopic characterization of Cucumis sativus stellacyanin in its nonglycosylated form. Protein Science. 5(11). 2184–2192. 29 indexed citations
20.
Hart, Peter, A.F. Monzingo, Arthur Donohue‐Rolfe, et al.. (1991). Crystallization of the B chain of Shiga-like toxin I from Escherichia coli. Journal of Molecular Biology. 218(4). 691–694. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026